Factors influencing simultaneous concentrations of carbamazepine and its epoxide in plasma

Therapeutic Drug Monitoring

Volumn 3, Issue 1, 1981, Pages 63-70

  McKauge, L ^a   Tyrer, J H ^a   Eadie, M J ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Carbamazepine; Epoxide; Plasma concentrations

Indexed keywords

CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; CLONAZEPAM; ETHOSUXIMIDE; METHYLPHENOBARBITAL; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; SULTIAME; VALPROIC ACID;

AGE; BODY WEIGHT; DRUG BLOOD LEVEL; DRUG MIXTURE; EPILEPSY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; PHARMACOKINETICS; SEX;

ADOLESCENT; ADULT; AGING; ANTICONVULSANTS; BIOTRANSFORMATION; CARBAMAZEPINE; DRUG INTERACTIONS; FEMALE; HUMAN; MALE; SEX FACTORS;

EID: 0019435493     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/00007691-198109000-00008     Document Type: Article

References (12)

1. Reynolds EH: Discussion. In: Tegretol in Epilepsy, ed. by CAS Wink, Nicholls and Co, Manchester, 1973
2. Rane A, Hojer B, Wilson JT: Kinetics of carbamazepine and its 10,1 l-epoxide metabolite in children. Clin Pharmacol Ther 19:276-283, 1976
3. Eichelbaum M, Bertilsson L, Lund L, Palmer L, Sjoqvist F: Plasma levels of carbamazepine and carbamazepine-10, 1 l-epoxide during carbamazepine therapy in epileptic patients. Eur J Clin Pharmacol 9:417-421, 1976
4. Johanessen SI, Gerna M, Bakke J, Strandjord RE, Morselli PL: CSF concentrations and plasma protein binding of carbamazepine and carbamazepine-10,1 l-epoxide in epileptic patients. Br J Clin Pharmacol 3:575-582, 1976
5. Monaco F, Riccio A, Benna P, Covacich A, Durelli L, Fantini M, Furlan PM, Gilli M, Mutani R, Gerna M, Morselli PM: Further observations on carbamazepine plasma level in epileptic patients. Neurology 26:936-943. 1976
6. Morselli PL, Bossi L, Gerna M: Pharmacokinetic studies with carbamazepine. In: International Symposium on Epileptic Seizures — Behaviour — Pain, ed. by W Birkmayer. Huber, Berne, 1975, pp 141-150
7. Eadie MJ, Tyrer JH: Anticonvulsant Therapy. Pharmacological Basis and Practice, 2nd ed. Churchill-Livingstone, Edinburgh, 1980
8. McKauge L, Tyrer JH, Eadie MJ: The epoxide of carbamazepine. Clin Exp Neurol 16:95-104, 1979
9. Hooper WD, DuBetz DK, Eadie MJ, Tyrer JH: Preliminary observations on the clinical pharmacology of carbamazepine ("Tegretol"). Proc Aust Assoc Neurol 11:189-198, 1974
10. Lander CM, Eadie MJ, Tyrer JH: Factors influencing plasma carbamazepine concentrations. Clin Exp Neurol 14:184-193, 1977
11. Cotter LM, Smith GA, Hooper WD, Tyrer JH, Eadie MJ: The bioavailability of carbamazepine. Proc Aust Assoc Neurol 12:123-128, 1975
12. Cotter LM, Eadie MJ, Hooper WD, Lander CM, Smith GA, Tyrer JH: The pharmacokinetics of carbamazepine. Eur J Clin Pharmacol 12:451-456, 1977